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Background: Definite stent thrombosis definition maximizes specificity, but it may be insufficiently sensitive to capture completely this relatively 
rare event. Sensitivity can be increased by including probable stent thrombosis in the analysis. In accordance with the Academic Research 
Consortium we assessed definite and probable stent thrombosis events in the SORT OUT IV trial, among patient treated with everolimus-eluting (EES) 
or sirolimus-eluting (SES).
Methods: Of 2,774 patients, 1,390 patients were assigned to receive the EES, and 1,384 patients were assigned to receive the SES. Definite and 
probable stent thromboses were assessed within 2 years.
Results: Definite stent thrombosis occurred within 2 years in 16 patients (0.6%) and definite/probable stent thrombosis occurred in 32 patients 
(1.2%). 
EES SES HR 95% CI
Definite stent thrombosis 3 (0.2%) 13 (0.9%) 0.23 (0.07 - 0.80)
Acute 0 (0.0%) 3 (0.3%) -
Subacute 2 (0.1%) 4 (0.3%) 0.50 (0.09 - 2.71)
Late 0 (0.0%) 2 (0.1%) -
Very Late 1 (0.1%) 4 (0.3%) 0.25 (0.03 - 2.22)
Probable stent thrombosis 12( 0.9%) 4( 0.3%) 3.00 (0.97 - 9.29)
Definite/probable stent thrombosis 15( 1.1%) 17( 1.2%) 0.88 (0.44 - 1.76)
Definite stent thrombosis occurred in 3 patients [0.2%] in the EES group and in 13 patients [0.9%] in the SES group (p = 0.021). Probable stent 
thrombosis occurred within 2 years in 12 patients [0.9%] in the EES group and in 4 patients [0.3%] in the SES group (p = 0.057). Probable stent 
thrombosis was caused by 11 unexplained deaths within the first 30 days (EES=7, SES=4) and 5 myocardial infarctions, which were related to 
documented acute ischemia in the territory of the implanted stent (EES=5, SES=0).
Conclusion: EES showed a significant reduced risk of definite stent thrombosis compared to SES whereas the combined rate of definite/probable 
stent thrombosis was equal in the two stent groups.
